The Role of AGEs in Cardiovascular Disease : Advanced glycation end products (AGEs) and their receptor (RAGE) in health and diseaseJANDELEIT-DAHM, Karin; COOPER, Mark E.Current pharmaceutical design. 2008, Vol 14, Num 10, pp 979-986, issn 1381-6128, 8 p.Article

The Role of Advanced Glycation End Products in Progression and Complications of DiabetesGOH, Su-Yen; COOPER, Mark E.The Journal of clinical endocrinology and metabolism. 2008, Vol 93, Num 4, pp 1143-1152, issn 0021-972X, 10 p.Article

Turning up the heat: heat shock proteins, hypertension and cardiovascular riskTHOMAS, Merlin C; COOPER, Mark E.Journal of hypertension. 2002, Vol 20, Num 9, pp 1713-1714, issn 0263-6352Article

Mechanisms of diabetic nephropathy role of hypertensionGIUNTI, Sara; BARIT, David; COOPER, Mark E et al.Hypertension (Dallas, Tex. 1979). 2006, Vol 48, Num 4, pp 519-526, issn 0194-911X, 8 p.Article

Epigenetics Mechanisms and Implications for Diabetic ComplicationsCOOPER, Mark E; EL-OSTA, Assam.Circulation research. 2010, Vol 107, Num 12, pp 1403-1413, issn 0009-7330, 11 p.Article

Apoptosis and angiotensin II: Yet another renal regulatory system?BONNET, Fabrice; ZEMIN CAO; COOPER, Mark E et al.Experimental nephrology. 2001, Vol 9, Num 5, pp 295-300, issn 1018-7782Article

Importance of advanced glycation end products in diabetes-associated cardiovascular and renal diseaseCOOPER, Mark E.American journal of hypertension. 2004, Vol 17, Num 12, pp 31S-38S, issn 0895-7061, 2Article

Angiotensin receptor blockers and the kidney : Possible advantages over ACE inhibition?COOPER, Mark E; WEBB, Randy L; DE GASPARO, Marc et al.Cardiovascular drug reviews (Print). 2001, Vol 19, Num 1, pp 75-86, issn 0897-5957Article

Mechanisms of diabetic vasculopathy : An overviewCOOPER, Mark E; BONNET, Fabrice; OLDFIELD, Matthew et al.American journal of hypertension. 2001, Vol 14, Num 5, pp 475-486, issn 0895-7061, 1Article

Oxidative Stress as a Major Culprit in Kidney Disease in DiabetesFORBES, Josephine M; COUGHLAN, Melinda T; COOPER, Mark E et al.Diabetes (New York, NY). 2008, Vol 57, Num 6, pp 1446-1454, issn 0012-1797, 9 p.Article

Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetesGUORONG MA; ALLEN, Terri J; COOPER, Mark E et al.Kidney international. 2004, Vol 66, Num 3, pp 1090-1098, issn 0085-2538, 9 p.Article

Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptorsXIAOLI ZHANG; LASSILA, Markus; COOPER, Mark E et al.Hypertension (Dallas, Tex. 1979). 2004, Vol 43, Num 2, pp 276-281, issn 0194-911X, 6 p.Article

Targets to retard the progression of diabetic nephropathyCOOPER, Mark E; JANDELEIT-DAHM, Karin; THOMAS, Merlin C et al.Kidney international. 2005, Vol 68, Num 4, pp 1439-1445, issn 0085-2538, 7 p.Article

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and futureKAHN, Steven E; COOPER, Mark E; DEL PRATO, Stefano et al.Lancet (British edition). 2014, Vol 383, Num 9922, pp 1068-1083, issn 0140-6736, 16 p.Article

Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both APT₁ and AT₂ receptorsRIZKALLA, Bishoy; FORBES, Josephine M; COOPER, Mark E et al.Journal of the American Society of Nephrology. 2003, Vol 14, Num 12, pp 3061-3071, issn 1046-6673, 11 p.Article

Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo ArmSKALI, Hicham; JULIE LIN; SCOTT-DOUGLAS, Nairne W et al.American journal of kidney diseases. 2013, Vol 61, Num 2, pp 238-246, issn 0272-6386, 9 p.Article

Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal FibrosisBO WANG; KOMERS, Radko; COOPER, Mark E et al.Journal of the American Society of Nephrology. 2012, Vol 23, Num 2, pp 252-265, issn 1046-6673, 14 p.Article

Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine TailBRASACCHIO, Daniella; OKABE, Jun; TIKELLIS, Christos et al.Diabetes (New York, NY). 2009, Vol 58, Num 5, pp 1229-1236, issn 0012-1797, 8 p.Article

c-Jun NH₂-Terminal Kinase Activity in Subcutaneous Adipose Tissue but Not Nuclear Factor-κB Activity in Peripheral Blood Mononuclear Cells Is an Independent Determinant of Insulin Resistance in Healthy IndividualsSOURRIS, Karly C; LYONS, Jasmine G; DE COURTEN, Barbora et al.Diabetes (New York, NY). 2009, Vol 58, Num 6, pp 1259-1265, issn 0012-1797, 7 p.Article

Effect of LDL Cholesterol and Treatment With Losartan on End-Stage Renal Disease in the RENAAL StudyTERSHAKOVEC, Andrew M; KEANE, William F; ZHONGXIN ZHANG et al.Diabetes care. 2008, Vol 31, Num 3, pp 445-447, issn 0149-5992, 3 p.Article

Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product-Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α-Dependent PathwayTHALLAS-BONKE, Vicki; THORPE, Suzanne R; COUGHLAN, Melinda T et al.Diabetes (New York, NY). 2008, Vol 57, Num 2, pp 460-469, issn 0012-1797, 10 p.Article

Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy : Post hoc analysis from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) trialEIJKELKAMP, Wouter B. A; ZHONGXIN ZHANG; DE ZEEUW, Dick et al.Journal of the American Society of Nephrology. 2007, Vol 18, Num 5, pp 1540-1546, issn 1046-6673, 7 p.Article

A study of VEGF and its receptors in two rat models of proteinuriaKANELLIS, John; LEVIDIOTIS, Vicki; KHONG, Tiffany et al.Nephron. 2004, Vol 96, Num 1, pp p26-p36, issn 0028-2766Article

ACE2, a new regulator of the renin-angiotensin systemBURRELL, Louise M; JOHNSTON, Colin I; TIKELLIS, Christos et al.Trends in endocrinology and metabolism. 2004, Vol 15, Num 4, pp 166-169, issn 1043-2760, 4 p.Article

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosisFORBES, Josephine M; TEO LOON YEE, Louis; COOPER, Mark E et al.Diabetes (New York, NY). 2004, Vol 53, Num 7, pp 1813-1823, issn 0012-1797, 11 p.Article